[ad_1] Recon | 01 May 2023 | By Joanne S. Eglovitch Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Focus: US FDA advisory committee votes against plan…
Tag: 5.9B
Astellas Pharma to Buy Iveric Bio for About $5.9B
[ad_1] The Japanese drugmaker said it agreed to acquire Iveric bio for about $5.9 billion to strengthen its capabilities in the ophthalmology field. [ad_2] Source link